A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma

Phase 2 Active not recruiting 63 enrolled Incyte Corporation

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is being conducted to determine the safety, tolerability, and preliminary efficacy of INCB099280 in participants with advanced Cutaneous Squamous Cell Carcinoma.

Timeline

Start: 2023-10-09
Primary completion: 2026-09-28
Completion: 2026-09-28

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	INCB099280	Unknown	—	—

A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma

Summary

Timeline

Drugs

Indications